Arazlo

Active Ingredient(s): Tazarotene
FDA Approved: * December 18, 2019
Pharm Company: * DOW PHARM
Category: Skin Care

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Arazlo Overview

Tazarotene, sold under the brand name Tazorac, among others, is a third-generation prescription topical retinoid.[1][2] It is primarily used for the treatment of plaque psoriasis and acne.[3] Tazarotene is also used as a therapeutic for photoaged and photodamaged skin.[3] Tazarotene is a member of the acetylenic class of retinoids.[3] Contents 1 Medical uses 1.1 Pregnancy 2 Contraindications 3 Adverse effects...

Read more Arazlo Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tazarotene

Recent Arazlo Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Tazarotene
  • Aerosol, Foam: 0.1%
  • Cream: 0.05%, 0.1%, 0.10%, 1%
  • Foam: 0.1%
  • Gel: 0.05%, 0.1%, 0.10%
  • Lotion: 0.045%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Arazlo: (1 result)

Sorted by National Drug Code
  • 0187-2098 Arazlo .45 mg/g Topical Lotion by Bausch Health Us LLC

Other drugs which contain Tazarotene or a similar ingredient: (5 results)